N. Weissmann (Giessen, Germany), A. Peacock (Glasgow, United Kingdom), D. Welsh (Glasgow, United Kingdom), I. Preston (Boston, United States of America)
Mir-17 modulates smooth muscle cell markers, apoptosis and BMPR-II levels in human pulmonary artery smooth muscle cells
G. Kollongod Ramanathan, P. Tamarapu, A. Younis, S. Jalali, S. Garcia, R. F. Lockey, N. Kolliputi (Tampa, United States Of America)
|  |
Vasopressin is involved in endothelin receptor antagonist-induced fluid retention in rat. Differential effect of selective ETA and dual ETA/ETB receptor antagonists
M. Vercauteren, D. Strasser, E. Vezzali, A. Stalder, M. Iglarz, P. Hess, M. Clozel (Allschwil, Switzerland)
| |
A potential new therapy for pulmonary hypertension with the use of compound 21, an angiotensin type 2 receptor (AT2R) agonist
E. Bruce, V. Shenoy, A. Rathinasabapathy, U. M. Steckelings, T. Unger, C. Sumners, M. K. Raizada, M. J. Katovich (Gainesville, United States Of America; Berlin, Germany)
|  |
A dose-response study of nilotinib and imatinib in experimental pulmonary hypertension
M. C. Chaumais, F. Perros, M. Molimard, S. Bouchet, P. Dorfmuller, C. Guignabert, S. Cohen-Kaminsky, M. Humbert, D. Montani (Le Plessis Robinson, France)
| |
Genistein rescues pulmonary hypertension and attenuates abnormal vasoconstriction in rats lungs
S. Kuriyama, Y. Morio, T. Nagaoka, K. Seyama, K. Takahashi (Tokyo, Japan)
| |
Modified exhaled nitric oxide measurement in monocrotaline-exposed rats to monitor pulmonary hypertension
M. S. Strobl, C. Schreiber, S. Hubmer, H. Bergmeister, I. M. Lang, D. Bonderman (Austria)
| |
Bone morphogenetic protein signaling in experimental nitrofen-induced congenital diaphragmatic hernia
M. Makanga, C. Dewachter, A. Vuckovic, B. Rondelet, R. Naeije, L. Dewachter (Brussels, Belgium)
| |
TSC1/mTOR pathway promotes hypoxia-induced pulmonary hypertension in mice
W. Wang, J. Liu, H. Guo, A.P. Ma, K.F. Xu, J. Wang (Beijing, China)
| |
Feasibility of eccentric exercise training (ECCt) in monocrotaline (MT) rats: Effects on survival, echocardiographic and hemodynamic parameters
I. Enache, S. Doutreleau, F. Favret, P. Di Marco, C. Pistea, B. Geny, A. Charloux (Strasbourg, France)
| |
Superior in vivo efficacy of macitentan: Comparison to other endothelin receptor antagonists
M. Iglarz, M. Rey, P. Hess, K. Kauser, M. Clozel (Allschwil, Switzerland)
| |
Resveratrol attenuates hypoxic pulmonary vascular remodeling in simulated high altitude-exposed rats: potential role of Hif-1α/NOX4/ROS inhibition
T. Wang, L.L. Guo, G.M. He, F. Luo, F.Q. Wen (Chengdu, China)
| |
Applying pharmacogenomics to pulmonary arterial hypertension (PAH): A target-based approach to therapy
S. Said, S. Hamidi (Stony Brook, Northport, United States Of America)
| |
Resolution of venous thrombus is depending on B-lymphocytes
M.K. Frey, M.P. Winter, A. Alimohammadi, A. Panzenboeck, S. Puthenkalam, D. Bonderman, I. Lang (Vienna, Austria)
| |
Prevention and partial reversal of monocrotaline-induced pulmonary arterial hypertension (PAH) by hsp90 inhibitors
C. Dimitropoulou, C. Snead, S. Litwin, Y. Su, J. Catravas (Augusta, United States Of America)
| |
Profibrotic cytokine TGF-β1 increases endothelial progenitor cell angiogenic properties
S. Evrard, C. d‘Audigier, L. Mauge, D. Israel-Biet, A.M. Fischer, P. Gaussem, D. Smadja (Paris, France)
| |
Unique receptor dissociation kinetics of the novel endothelin receptor antagonist macitentan
J. Gatfield, C. Mueller Grandjean, T. Sasse, B. Steiner, P. Steiner, M. Iglarz, K. Kauser, M. Clozel, O. Nayler (Allschwil, Switzerland)
| |
Pulmonary gene expression of tenascin-C and fibronectin in chronic obtructive pulmonary disease (COPD)
M. Munoz-Esquerre, S. Estany, M. López, M. Molina-Molina, I. Escobar, R.M. Penin, V. Peinado, J.A. Barberà, J. Dorca, S. Santos (Barcelona, Spain)
| |
Effects of a soluble guanylate cyclase stimulator, BAY 41-8543, upon right ventricular function in experimental pulmonary embolism
J. Watts, M. Gellar, M. B. Fulkerson, J. Kline (Charlotte, United States Of America)
| |
Fluorescence activated cell sorting for simultaneous assessment of nine surface markers of circulating endothelial progenitor cells in pulmonary hypertension
V. Foris, G. Kovacs, L. Marsh, M. Tscherner, A. Olschewski, H. Olschewski (Graz, Austria)
| |